Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month – Markets Insider
|
Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month
Markets Insider Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, announced today that CGEN-15032, a newly-disclosed novel myeloid and epithelial immuno-oncology target, will be … |
